Dolby Laboratories (DLB)
(Delayed Data from NYSE)
$78.68 USD
+0.31 (0.40%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $78.64 -0.04 (-0.05%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DLB 78.68 +0.31(0.40%)
Will DLB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for DLB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DLB
Is the Options Market Predicting a Spike in Dolby Laboratories (DLB) Stock?
Dolby Laboratories (DLB) Signs Deal to Acquire GE Licensing
DLB: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights Crocs, PlayAGS, Dolby Laboratories, Netflix and Royal Caribbean Cruises
New Strong Buy Stocks for May 31st
5 Solid Stocks to Buy on Rebound in Consumer Confidence
Other News for DLB
One buy and one sell recommendation from each sector within SMID caps - Oppenheimer
Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2024 Financial Results
Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation
What 4 Analyst Ratings Have To Say About Dolby Laboratories
Dolby Laboratories To Acquire GE Licensing In $429M Cash Deal: Strengthens Patent Portfolio